-transparent.png){kind=logo}
An outbreak of Serratia marcescens involving 42 patients admitted to the general intensive care unit of the Hospital of Varese, Italy, occurred from March 1994 to August 1995. The causative strains were resistant to oxyimino-cephalosporins and monobactams due to their production of an extended-spectrum beta-lactamase. Another outbreak caused by Serratia marcescens strains had occurred in the same unit a few months earlier, from February to October 1993, with the strains involved producing a novel TEM-derived extended-spectrum beta-lactamase. In order to verify whether there were any relationships between isolates from the two epidemics, the strains and their enzymes were characterized. Biochemical data and gene amplification experiments showed that the isolates of the second outbreak harbored a non-conjugative plasmid of approximately 48 kb, codifying for the production of an SHV-derived extended-spectrum beta-lactamase with pI 8.2. Restriction fragment length polymorphism analysis of total genomic DNA by pulsed-field gel electrophoresis of Serratia marcescens isolates unambiguously identified two different bacterial clones responsible for the two epidemics. Epidemiological and microbiological investigations demonstrated the long persistence of Serratia marcescens strains and their circulation in other hospital wards, thus suggesting their possible role as a long-term reservoir for further epidemic spread.
F Luzzaro, and
M Perilli, and
R Migliavacca, and
G Lombardi, and
P Micheletti, and
A Agodi, and
S Stefani, and
G Amicosante, and
L Pagani
September 2008,
The Journal of hospital infection,
F Luzzaro, and
M Perilli, and
R Migliavacca, and
G Lombardi, and
P Micheletti, and
A Agodi, and
S Stefani, and
G Amicosante, and
L Pagani
April 2003,
Diagnostic microbiology and infectious disease,
F Luzzaro, and
M Perilli, and
R Migliavacca, and
G Lombardi, and
P Micheletti, and
A Agodi, and
S Stefani, and
G Amicosante, and
L Pagani
November 1994,
FEMS immunology and medical microbiology,
F Luzzaro, and
M Perilli, and
R Migliavacca, and
G Lombardi, and
P Micheletti, and
A Agodi, and
S Stefani, and
G Amicosante, and
L Pagani
June 2006,
Japanese journal of infectious diseases,
F Luzzaro, and
M Perilli, and
R Migliavacca, and
G Lombardi, and
P Micheletti, and
A Agodi, and
S Stefani, and
G Amicosante, and
L Pagani
May 2003,
Journal of clinical microbiology,
F Luzzaro, and
M Perilli, and
R Migliavacca, and
G Lombardi, and
P Micheletti, and
A Agodi, and
S Stefani, and
G Amicosante, and
L Pagani
October 2008,
Journal of chemotherapy (Florence, Italy),
F Luzzaro, and
M Perilli, and
R Migliavacca, and
G Lombardi, and
P Micheletti, and
A Agodi, and
S Stefani, and
G Amicosante, and
L Pagani
March 2011,
Revista clinica espanola,
F Luzzaro, and
M Perilli, and
R Migliavacca, and
G Lombardi, and
P Micheletti, and
A Agodi, and
S Stefani, and
G Amicosante, and
L Pagani
June 2006,
Journal of chemotherapy (Florence, Italy),
F Luzzaro, and
M Perilli, and
R Migliavacca, and
G Lombardi, and
P Micheletti, and
A Agodi, and
S Stefani, and
G Amicosante, and
L Pagani
December 1995,
The Journal of antibiotics,
F Luzzaro, and
M Perilli, and
R Migliavacca, and
G Lombardi, and
P Micheletti, and
A Agodi, and
S Stefani, and
G Amicosante, and
L Pagani
September 2008,
Archives of internal medicine,
